BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38001032)

  • 1. Late clinical and echocardiographic results with the Magna Ease© pericardial aortic bioprosthesis.
    Anselmi A; Aymami M; Tomasi J; D'Alessandro G; Langanay T; Corbineau H; Mancini J; Flecher E; Verhoye JP
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38001032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine bioprostheses for surgical aortic valve replacement: very long-term performance of a third-generation device.
    Anselmi A; Tomasi J; Aymami M; Mancini J; Nesseler N; Langanay T; Flecher E; Verhoye JP
    J Cardiovasc Med (Hagerstown); 2023 Aug; 24(8):514-521. PubMed ID: 37409596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
    Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
    J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes Following Surgical Aortic Bioprosthesis Implantation.
    Rodriguez-Gabella T; Voisine P; Dagenais F; Mohammadi S; Perron J; Dumont E; Puri R; Asmarats L; Côté M; Bergeron S; Pibarot P; Rodés-Cabau J
    J Am Coll Cardiol; 2018 Apr; 71(13):1401-1412. PubMed ID: 29598859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trifecta Versus Perimount Magna Ease Aortic Valve Prostheses.
    Biancari F; Valtola A; Juvonen T; Husso A; Dahlbacka S; Laakso T; Jalava MP; Tauriainen T; Ahvenvaara T; Kinnunen EM; Niemelä M; Mäkikallio T; Eskola M; Virtanen MPO; Maaranen P; Rosato S; Anttila V; Vento A; Airaksinen J; Raivio P
    Ann Thorac Surg; 2020 Sep; 110(3):879-888. PubMed ID: 32061588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability and clinical experience using a bovine pericardial prosthetic aortic valve.
    Lehmann S; Jawad K; Dieterlen MT; Hoyer A; Garbade J; Davierwala P; Borger MA
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1742-1749. PubMed ID: 31932059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural valve deterioration after aortic valve replacement with the Trifecta valve.
    Werner P; Gritsch J; Scherzer S; Gross C; Russo M; Coti I; Kocher A; Laufer G; Andreas M
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(1):39-46. PubMed ID: 33221889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magna ease bioprosthetic aortic valve: mid-term haemodynamic outcomes in 1126 patients.
    Thorp SD; Khazaal J; Yu G; Parker JL; Timek TA
    Interact Cardiovasc Thorac Surg; 2021 May; 32(6):839-845. PubMed ID: 33570145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of surgical aortic valve replacement using Carpentier-Edwards PERIMOUNT bioprosthesis series in elderly patients with severe aortic valve stenosis: a retrospective cohort study.
    Nishioka N; Yamada A; Ujihira K; Iba Y; Maruyama R; Hatta E; Kurimoto Y; Nakanishi K
    Gen Thorac Cardiovasc Surg; 2016 Dec; 64(12):728-734. PubMed ID: 27491542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rigorous patient-prosthesis matching of Perimount Magna aortic bioprosthesis.
    Nakamura H; Yamaguchi H; Takagaki M; Kadowaki T; Nakao T; Amano A
    Asian Cardiovasc Thorac Ann; 2015 Mar; 23(3):261-6. PubMed ID: 25033914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
    Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
    J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No clinical effect of prosthesis-patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid-term follow-up: an analysis from the NOTION trial.
    Thyregod HG; Steinbrüchel DA; Ihlemann N; Ngo TA; Nissen H; Kjeldsen BJ; Chang Y; Hansen PB; Olsen PS; Søndergaard L
    Eur J Cardiothorac Surg; 2016 Oct; 50(4):721-728. PubMed ID: 27005980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after aortic valve replacement using a 19-mm bioprosthesis.
    Okamura H; Kusadokoro S; Mieno M; Kimura N; Yamaguchi A
    Eur J Cardiothorac Surg; 2022 Feb; 61(3):625-634. PubMed ID: 34431991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.
    Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH;
    JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
    Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of aortic bioprostheses: An 18-year experience.
    Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Aortic Bioprosthesis Durability: A Single-Center Experience.
    Moroni F; Ziviello F; Federico F; Di Stefano D; Beneduce A; Vella CS; Ancona F; Ingallina G; Ancona M; Ferri LA; Russo F; Bellini B; Agricola E; Chieffo A; Montorfano M
    Cardiovasc Revasc Med; 2022 Oct; 43():1-6. PubMed ID: 35690553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms.
    Suzuki R; Ito T; Suzuki M; Ohori S; Takayanagi R; Miura S
    Asian Cardiovasc Thorac Ann; 2022 Sep; 30(7):797-806. PubMed ID: 35603636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.
    Bavaria JE; Desai ND; Cheung A; Petracek MR; Groh MA; Borger MA; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):590-7. PubMed ID: 23477687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.